Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001295 · ClinicalTrials.gov registry record
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,145
- Enrollment target
NCT00001295: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001295 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001295 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,145 participants
- Enrollment target
Study Summary
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,145 participants |
| Start Date | 1992-01-29 |
| Est. Completion | 2016-08-23 |
What the finished NCT00001295 record still lists
NCT00001295 is an observational study that tracks outcomes without assigning an intervention. Its 2,145 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001295 about?
NCT00001295 is a clinical study titled "Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease". This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.
What is the current status of trial NCT00001295?
This trial is currently completed. The enrollment target is 2,145 participants. The study started on 1992-01-29. Estimated completion is 2016-08-23.
Who is sponsoring clinical trial NCT00001295?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI